Abstract
Proper cellular functioning is dependent on the timely association of thousands of proteins in discrete complexes. A major challenge in the post genomic era is the elucidation of these diverse protein complexes and networks that govern mammalian cellular function and cell fate. Identification of the individual components of these arrangements is vital to the understanding of their function in biological processes. Currently, a widely used technique for the identification of protein complexes is a combinational approach of Tandem Affinity Purification coupled with Mass Spectrometry (TAP-MS). This technique was originally developed for the study of the yeast proteome but has since been adapted for studies of the mammalian system. This review discusses the applications of TAP-MS to the mammalian proteome. Our focus includes the technical improvements made in each step of the TAP-MS pipeline including vector design, delivery of the TAP construct into cells, expression of bait proteins, purification strategies and finally the identification of the protein complexes by mass spectrometry.
Keywords: Tandem affinity purification, mass spectrometry, protein complexes, protein purification
Current Proteomics
Title: Advances in the Study of Mammalian Proteome by Tandem Affinity Purification – Mass Spectrometry
Volume: 7 Issue: 1
Author(s): Vahab D. Soleimani and Michael A. Rudnicki
Affiliation:
Keywords: Tandem affinity purification, mass spectrometry, protein complexes, protein purification
Abstract: Proper cellular functioning is dependent on the timely association of thousands of proteins in discrete complexes. A major challenge in the post genomic era is the elucidation of these diverse protein complexes and networks that govern mammalian cellular function and cell fate. Identification of the individual components of these arrangements is vital to the understanding of their function in biological processes. Currently, a widely used technique for the identification of protein complexes is a combinational approach of Tandem Affinity Purification coupled with Mass Spectrometry (TAP-MS). This technique was originally developed for the study of the yeast proteome but has since been adapted for studies of the mammalian system. This review discusses the applications of TAP-MS to the mammalian proteome. Our focus includes the technical improvements made in each step of the TAP-MS pipeline including vector design, delivery of the TAP construct into cells, expression of bait proteins, purification strategies and finally the identification of the protein complexes by mass spectrometry.
Export Options
About this article
Cite this article as:
Soleimani D. Vahab and Rudnicki A. Michael, Advances in the Study of Mammalian Proteome by Tandem Affinity Purification – Mass Spectrometry, Current Proteomics 2010; 7 (1) . https://dx.doi.org/10.2174/157016410790979626
DOI https://dx.doi.org/10.2174/157016410790979626 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Integrase Interactor 1 in Health and Disease
Current Protein & Peptide Science Improvement of Nonviral Gene Therapy by Epstein-Barr Virus (EBV)-based Plasmid Vectors
Current Gene Therapy Advances in Translational Pharmacological Investigations in Identifying and Validating Molecular Targets of Natural Product Anticancer Agents
Current Cancer Drug Targets Mechanisms of Resistance to Photodynamic Therapy
Current Medicinal Chemistry Small Molecule Tyrosine Kinase Inhibitors: Potential Role in Pediatric Malignant Solid Tumors
Current Cancer Drug Targets Animal Models of Systemic Sclerosis
Current Pharmaceutical Design Skp2 Inhibitors: Novel Anticancer Strategies
Current Medicinal Chemistry Anti-cancer Peptides from Ras-P21 and P53 Proteins
Current Pharmaceutical Design Ex Vivo Gene Transfer for Improvement of Transplanted Pancreatic Islet Viability and Function
Current Pharmaceutical Design Synthesis, in Vitro and in Vivo Anticancer Activity of Hybrids of 3- Hydroxy-indolin-2-one and 2,3-Dihydroquinolin-4(1H)-one
Letters in Drug Design & Discovery Traditional Chinese Medicines (TCMs) for Molecular Targeted Therapies of Tumours
Current Drug Discovery Technologies Human Immunodeficiency Virus-Associated Malignancies: A Therapeutic Update
Current HIV Research Liposome-Nanogel Structures for Future Pharmaceutical Applications
Current Pharmaceutical Design Drug Delivery Systems and Combination Therapy by Using Vinca Alkaloids
Current Topics in Medicinal Chemistry Secretory Clusterin as a Novel Molecular-targeted Therapy for Inhibiting Hepatocellular Carcinoma Growth
Current Medicinal Chemistry Transcriptome and Proteome Analyses of Drug Interactions with Natural Products
Current Drug Metabolism Phosphatidylinositol 3-kinase Signaling as a Therapeutic Target for Cervical Cancer
Current Cancer Drug Targets Endothelial Chemokines in Autoimmune Disease
Current Pharmaceutical Design Role of MMPs in Metastatic Dissemination: Implications for Therapeutic Advances
Current Pharmaceutical Biotechnology The Applicability of mTOR Inhibition in Solid Tumors
Current Cancer Drug Targets